Microbiome
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
42
NCT04540406
NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 2, 2021
Completion: Mar 14, 2022
Loading map...